logo

For the Inventor, By the Inventor

Blacksburg, VA, United States of America

Landos Biopharma, Inc.

USPTO Granted Patents = 18


Trademarks = 5

Forward Citations = 53

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Josep Bassaganya-Riera (18 out of 38 patents)

silverMedal Raquel Hontecillas (18 out of 31 patents)

bronzeMedal Andrew Leber (11 out of 16 patents)

4.  Adria Carbo Barrios (7 out of 9 patents)

5.  Richard Gandour (7 out of 12 patents)

6.  Julian D Cooper (7 out of 12 patents)

7.  Nuria Tubau-Juni (2 out of 3 patents)


18 patents:

1. 11680045 - NLRX1 ligands (2023-06-20),
2. 11597717 - Substituted imidazoles as PLXDC2 ligands (2023-03-07),
3. 11571419 - Lanthionine synthetase C-like 2-based therapeutics (2023-02-07),
4. 11548885 - NLRX1 ligands (2023-01-10),
5. 11492342 - Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone) (2022-11-08),
6. 11459310 - LANCL ligands (2022-10-04),
7. 11377437 - Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same (2022-07-05),
8. 11197891 - Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith (2021-12-14),
9. 11117881 - Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same (2021-09-14),
10. 11066364 - NLRX1 ligands (2021-07-20),
11. 10849895 - Lanthionine synthetase C-like 2-based therapeutics (2020-12-01),
12. 10682349 - Lanthionine synthetase C-like 2-based therapeutics (2020-06-16),
13. 10676436 - NLRX1 ligands (2020-06-09),
14. 10493072 - Lanthionine synthetase C-like 2-based therapeutics (2019-12-03),
15. 10487057 - NLRX1 ligands (2019-11-26),
Company Overview
Landos Biopharma, Inc. is a biopharmaceutical company based in Blacksburg, Virginia, focused on developing innovative therapies for autoimmune diseases. The company specializes in leveraging its proprietary drug discovery platform to identify and advance novel treatments that target specific pathways involved in immune system regulation. With a commitment to addressing unmet medical needs, Landos aims to improve the quality of life for patients suffering from chronic inflammatory conditions through its research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Landos Biopharma, Inc. USPTO Patent Assignee Logo
18 Patents

#7 in Blacksburg, VA

#300 in Virginia

#17,974 in US

#34,244 in the World

Blacksburg, VA (US)
Blacksburg, VA, United States of America

Landos Biopharma, Inc.

Forward Citations = 53

7 inventors:

goldMedal Josep Bassaganya-Riera (18 out of 38 patents)

silverMedal Raquel Hontecillas (18 out of 31 patents)

bronzeMedal Andrew Leber (11 out of 16 patents)

4.  Adria Carbo Barrios (7 out of 9 patents)

5.  Richard Gandour (7 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Landos Biopharma, Inc.. Retrieved from https://idiyas.com/company/landos-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…